Printer Friendly

DIAGNOSTEK ANNOUNCES REVENUES FOR FISCAL YEAR 1991

 DIAGNOSTEK ANNOUNCES REVENUES FOR FISCAL YEAR 1991
 ALBUQUERQUE, N.M., May 29 /PRNewswire/ -- Diagnostek, Inc.


(NYSE: DXK), announced today that it expects that revenues and earnings per share for the fiscal year ended March 31, 1992, will be $293.8 million and $.61 per share, respectively. These preliminary unaudited results represent an increase of 30 percent over the prior year revenues of $225.2 million and an increase of 74 percent over prior year earnings per share of $.35.
 For the quarter ended March 31, 1992, revenues and earnings per share were $80.3 million and $.17 per share, respectively. Revenues for the quarter increased 25 percent from $64.3 million for the prior year period and earnings per share increased 55 percent from $.11 per share for the prior year period.
 Revenues from the company's mail service pharmacy business, Health Care Services, Inc. (HCS), for the fiscal year ended March 31, 1992, were $207.6 million and $150.4 million for the prior year, an increase of 38 percent. HCS' operating income for the year is expected to be $17.6 million compared to $12.6 million for the prior year, an increase of 40 percent. Notwithstanding HCS' increase in revenues and operating income there were certain unanticipated decreases in HCS' operating margin in the quarter ended March 31, 1992. The effects of such decreases reduced the company's anticipated earnings per share by approximately $.03 per share. Other minor non-recurring items reduced anticipated earnings per share by approximately $.01 per share. The company expects to have its fiscal year and financial results completed and released next week.
 -0- 5/29/92
 /CONTACT: Vince Villanueva or Dennis Evans of Diagnostek, 505-345-8080; or Julius Golden of Group West, Incorporated, 505-883-6940, for Diagnostek/
 (DXK) CO: Diagnostek, Inc. ST: New Mexico IN: MTC SU: ERP


GK -- NY001 -- 5053 05/29/92 08:19 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 29, 1992
Words:311
Previous Article:AUTOSTACK/SEA-LAND START INNOVATIVE AUTOMOBILE TRANSPORTATION SERVICE
Next Article:CARMEL CONTAINER SYSTEMS REPORTS RESULTS FOR THE QUARTER ENDED MARCH 31, 1992
Topics:


Related Articles
DIAGNOSTEK ANNOUNCES SECOND QUARTER RESULTS
DIAGNOSTEK ANNOUNCES FINANCIAL RESULTS
DIAGNOSTEK ANNOUNCES FINANCIAL RESULTS
DIAGNOSTEK FISCAL 1993 THIRD QUARTER RESULTS
DIAGNOSTEK CONFIRMS CONTINUATION OF FORD RELATIONSHIP
DIAGNOSTEK REPORTS SOLID GROWTH IN ITS PRESCRIPTION MANAGEMENT BUSINESS
DIAGNOSTEK REPORTS EARLY TERMINATION OF CIGNA CONTRACTS
DIAGNOSTEK REPORTS $0.17 PER SHARE FIRST QUARTER NET EARNINGS; REVENUES UP 73% FROM PRIOR YEAR
DIAGNOSTEK REPORTS $0.18 PER SHARE SECOND QUARTER NET EARNINGS SIX MONTH EPS AT $0.34, UP 48% FROM PRIOR YEAR
VALUE HEALTH MOVES FORWARD WITH DIAGNOSTEK ACQUISITION

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters